Clinical Trials Browser

Camurati-Engelmann Syndrome, Fibrosis, Head and Neck Neoplasms, Neoplasms, Radiation Injuries

NCT04551950 2024-03-08

Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046)

Phase 1 Completed

25 enrolled 14 charts

Gynecologic

Uterine Cervical Neoplasms, Camurati-Engelmann Syndrome

NCT03833661 2023-10-25

M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)

Phase 2 Completed

159 enrolled 23 charts

Gastrointestinal

Biliary Tract Neoplasms, Camurati-Engelmann Syndrome, Gallbladder Neoplasms, Cholangiocarcinoma

NCT02178358 2022-02-25

A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma

Phase 2 Completed

132 enrolled 25 charts

Gastrointestinal

Camurati-Engelmann Syndrome, Carcinoma, Hepatocellular

NCT01620970 2021-05-14

PF-03446962 in Relapsed or Refractory Urothelial Cancer

Phase 2 Completed

14 enrolled

Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Camurati-Engelmann Syndrome, Neoplasm Metastasis, Recurrence

NCT00085670 2020-09-10

Cytokine Gene Polymorphisms in Bone Marrow Failure

Completed

79 enrolled

Bone Marrow Diseases, Camurati-Engelmann Syndrome

NCT02160106 2019-05-09

First in Human Dose Escalation Study of Vactosertib (TEW-7197) in Subjects With Advanced Stage Solid Tumors

Phase 1 Completed

35 enrolled

Keratoacanthoma familial, Camurati-Engelmann Syndrome, Neoplasm Metastasis, Neoplasms

NCT01401062 2019-03-05

Fresolimumab and Radiotherapy in Metastatic Breast Cancer

Phase 2 Completed

23 enrolled 8 charts

Breast

Breast Neoplasms, Camurati-Engelmann Syndrome

NCT00889954 2018-09-18

HERCREEM

Phase 1 Completed

20 enrolled

Camurati-Engelmann Syndrome

NCT00686738 2016-03-23

Development of Indices Predicting Response to Pre-operative Chemotherapy in Osteosarcoma Patients

Completed

20 enrolled

Sarcoma

Camurati-Engelmann Syndrome, Osteosarcoma

NCT00431561 2013-12-03

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

Phase 2 Completed

141 enrolled

CNS

Astrocytoma, Brain Neoplasms, Camurati-Engelmann Syndrome, Glioblastoma, Neoplasms

NCT00001378 2008-03-04

A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer

Phase 1 Completed

75 enrolled

Breast

Breast Neoplasms, Camurati-Engelmann Syndrome

Clinical Trials

Rehabilitation Assessment and Progress Tracking System Based on Video Images for Dysphagic Patients

Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046)

M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)

A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma

PF-03446962 in Relapsed or Refractory Urothelial Cancer

Cytokine Gene Polymorphisms in Bone Marrow Failure

First in Human Dose Escalation Study of Vactosertib (TEW-7197) in Subjects With Advanced Stage Solid Tumors

Fresolimumab and Radiotherapy in Metastatic Breast Cancer

HERCREEM

Development of Indices Predicting Response to Pre-operative Chemotherapy in Osteosarcoma Patients

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer